Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Carfilzomib is a medication used for the treatment of multiple myeloma.
Carfilzomib is a proteasome inhibitor, which works by blocking the action of proteasomes in the cells, leading to the destruction of cancer cells.
It is often used in combination with other medications such as lenalidomide, dexamethasone, or daratumumab.
see also:
Carfilzomib + Daratumumab + Dexamethasone, & Multiple Myeloma
[Carfilzomib + Dexamethason…